Efferon
PrivateLast Round
Series A
Jun 3, 2026
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Efferon is a therapeutic devices company that develops and manufactures advanced therapeutic devices for the treatment of sepsis and multiple organ failure syndrome through innovative extracorporeal blood purification technologies.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Efferon Comparables
Compare Efferon with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alteco Medical AB | 88% | |
| ExThera Medical | 83% | |
| Cytosorbents Corporation | 83% |
Efferon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 3, 2026 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2026
$3M raised in Seed round.
- May 19, 2026
Monthly visitors grew 234% MoM, reaching 4.6K.
Efferon Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Efferon's valuation, stock price, and market status.
Is Efferon a public or private company?
Efferon is a private company.
What is the current stock price of Efferon?
Efferon is a private company with no public stock price. No recent secondary market data is available.
How much is Efferon worth (valuation)?
Valuation information for Efferon is not publicly available.
Can I buy Efferon stock?
Efferon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Efferon's last funding round?
Efferon's most recent funding round was Seed on May 21, 2026.
Who are the main investors in Efferon?
Investor information for Efferon is not publicly disclosed.
Will Efferon IPO soon?
No public IPO plans have been announced for Efferon.
How can I track Efferon secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Efferon's secondary market activity and sign up for updates.